On these bases, in the present study, the relationship between methDNA and SLC22A17 expression in CM was investigated through computational approaches and further studied in both melanoma cell lines and tissue samples derived from CM patients. The gene discussed is SLC22A17; the disease is cutaneous mastocytosis.